Gardasil 9

Gardasil 9 is a vaccine designed to protect against human papillomavirus (HPV) types 31, 16, 18, 11, 33, 45, 52, and 58. It is administered intramuscularly and is manufactured by Merck Sharp & Dohme B.V.

Gardasil 9 is primarily used for the prevention of certain types of HPV infections. These infections are linked to various health issues, including cervical, vulvar, vaginal, and anal cancers, as well as genital warts. The vaccine is intended for use in individuals who have not previously been infected with the targeted HPV types.

Common effects of Gardasil 9 may include pain, swelling, or redness at the injection site. Some individuals might experience headaches, fatigue, or mild fever following vaccination. These effects are generally temporary and resolve on their own.

Gardasil 9 should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to discuss any medical conditions or allergies with a healthcare provider before receiving the vaccine.

There are no specific known interactions with Gardasil 9, but it is always advisable to inform healthcare providers about all medications and supplements being taken. The vaccine should not be mixed with other vaccines in the same syringe unless specifically directed by a healthcare professional.